Primary thrombocythemia
St. Luke's Hospital
Main Number: 314-434-1500 Emergency Dept: 314-205-6990 Patient Billing: 888-924-9200
Find a Physician Payment Options Locations & Directions
Follow us on: facebook twitter Mobile Email Page Email Page Print Page Print Page Increase Font Size Decrease Font Size Font Size
America's 50 Best Hospitals
Meet the Doctor
Spirit of Women
Community Health Needs Assessment
Home > Health Information

Multimedia Encyclopedia

Primary thrombocythemia

Definition

Primary thrombocythemia is when the bone marrow is making too many platelets without a known cause. Platelets are essential for blood clotting.

Blood clotting

Watch this video about:
Blood clotting

Alternative Names

Essential thrombocythemia; Essential thrombocytosis

Causes

Primary thrombocythemia is a disorder that is caused by too much growth of a type of cell that is used to make blood cells. Although the platelets are mostly affected, the red blood cells and white blood cells may also be involved. This condition slowly gets worse over time.

The disease is in the same family of disorders as:

Usually it affects people in middle age. It can also be seen in younger patients, especially females under age 40.

People with this condition make too many platelets and may have a problem with blood clots (thrombosis). Because these platelets do not work normally, bleeding is also a common problem.

Symptoms

  • Bleeding from the gastrointestinal tract, respiratory system, urinary tract, or skin
  • Bleeding from the gums
  • Bleeding (prolonged) from surgical procedures or tooth removal
  • Bloody stools
  • Dizziness
  • Easy bruising
  • Headache
  • Nosebleeds (epistaxis)
  • Numbness of the hands or feet
  • Ulcers on the fingers or toes

The condition may even cause strokes in some people.

Exams and Tests

This condition is often detected on blood tests done for other reasons, before there are any symptoms.

A physical exam may show an enlarged spleen or liver. There may be abnormal blood flow in the toes or feet, as well as skin damage caused by that abnormal blood flow.

Other tests may include:

Treatment

If a patient has life-threatening complications, a procedure to remove platelets directly from the blood (platelet pheresis) can quickly decrease the platelet count.

Long-term use of medications to decrease the platelet count can reduce both bleeding and clotting complications. The most commonly used medications include hydroxyurea, interferon-alpha, or anagrelide.

In patients who are at high risk for clotting (older patients, those with very high platelet levels or who have had past clotting episodes), aspirin at a low dose (81 to 100 mg per day) decreases clotting episodes.

Many patients do not need any treatment. However, the health care provider should monitor their condition.

Outlook (Prognosis)

The outcome varies. Most people go long periods of time without complications and have a normal life expectancy. In a very small number of patients, complications from bleeding (hemorrhage) and blood clots (thrombosis) can cause serious problems.

In a small number of patients, the disease will change into acute leukemia or myelofibrosis.

Possible Complications

  • Acute leukemia or myelofibrosis
  • Severe bleeding (hemorrhage)
  • Thrombotic episodes (stroke, heart attack, or blood clots in the hands or feet)

When to Contact a Medical Professional

Call your health care provider:

References

Finazzi G, Xu M, Barbui T, Hoffman R. Essential thrombocythemia. In: Hoffman R, Benz EJ Jr., Shattil SJ, et al, eds. Hoffman Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingstone Elsevier;2008:chap 127.

Tefferi A. Myeloproliferative disorders: Essential thrombocythemia and primary myelofibrosis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 177.


Review Date: 2/28/2011
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 


Back  |  Top
About Us
Contact Us
History
Mission
Locations & Directions
Quality Reports
Annual Reports
Honors & Awards
Community Health Needs
Assessment

Newsroom
Services
Brain & Spine
Cancer
Heart
Maternity
Orthopedics
Pulmonary
Sleep Medicine
Urgent Care
Women's Services
All Services
Patients & Visitors
Locations & Directions
Find a Physician
Tour St. Luke's
Patient & Visitor Information
Contact Us
Payment Options
Financial Assistance
Send a Card
Mammogram Appointments
Health Tools
My Personal Health
mystlukes
Spirit of Women
Health Information & Tools
Clinical Trials
Health Risk Assessments
Employer Programs -
Passport to Wellness

Classes & Events
Classes & Events
Spirit of Women
Donate & Volunteer
Giving Opportunities
Volunteer
Physicians & Employees
For Physicians
Remote Access
Medical Residency Information
Pharmacy Residency Information
Physician CPOE Training
Careers
Careers
St. Luke's Hospital - 232 South Woods Mill Road - Chesterfield, MO 63017 Main Number: 314-434-1500 Emergency Dept: 314-205-6990 Patient Billing: 888-924-9200
Copyright © St. Luke's Hospital Website Terms and Conditions  |  Privacy Policy  |  Patient Notice of Privacy Policies PDF Sitemap St. Luke's Mobile